Abstract
Optimization of the cellular and pharmacological activity of a novel series of PI3 kinase inhibitors targeting multiple isoforms is described.
MeSH terms
-
Administration, Oral
-
Animals
-
Benzoxazines / chemical synthesis*
-
Benzoxazines / chemistry
-
Benzoxazines / pharmacology*
-
Combinatorial Chemistry Techniques
-
Inhibitory Concentration 50
-
Isoenzymes / antagonists & inhibitors
-
Male
-
Molecular Structure
-
Phosphoinositide-3 Kinase Inhibitors*
-
Pyrazoles / chemical synthesis*
-
Pyrazoles / chemistry
-
Pyrazoles / pharmacology*
-
Rats
-
Rats, Wistar
-
Structure-Activity Relationship
Substances
-
Benzoxazines
-
Isoenzymes
-
Phosphoinositide-3 Kinase Inhibitors
-
Pyrazoles